● Formerly known as the R&D Department of Fujian Boro Pharmaceutical Co., Ltd., we have been investing in and managing the research and development of new products since 2002, and have obtained four product registration approvals (sodium phosphatidylcholine tablets, famotidine calcium magnesium chewable tablets, rifampicin sodium for injection, and rifampicin sodium for injection), successfully transferring to third-party production enterprises for production and listing for sale.